Overview: Next Cell Therapy processes should start with a cell isolation multi-parameters selection to ensure the purity, a key attribute for patient safety. The development of Clinical/GMP grade equipment in close collaboration allows to achieve perfected equipment in line with the needs of cell therapy

Agenda

12:30pm Panel

1:10pm Q&A

Speakers

Nadia Lounnas-Mourey Ph.D  Associate Director Process development, Sangamo Therapeutics France

Aditi Singh, Ph.D, Global Senior Marketing Manager, Sony Biotechnology

Cedric Ait Mansour, Global Senior Manager Market Development – New Products, Sony Biotechnology